A Pragmatic Trial to Evaluate the Intermediate-Term Effects of Early, Aggressive Versus Escalation Therapy in People with Multiple Sclerosis (Traditional versus Early Agressive Therapy for Multiple Sclerosis (TREAT-MS) Trial

Grant

Date/time Interval

  • September 11, 2018 - February 1, 2024
  • Total Award Amount

  • 244412.00
  • Direct Costs

  • 174579.00
  • Sponsor Award Id

  • 2003787244
  • Contributor

  • Benjamin Jones   Investigator  
  • John Rinker II   Investigator  
  • Khurram Bashir   Investigator  
  • William Meador   Principal Investigator